Articles From: Lone Star Value Delivers Open Letter To Antares Chairman And CEO to Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing


NEW YORK , June 18, 2014 /PRNewswire/ -- Lone Star Value Investors, LP (together with its affiliates, "Lone Star Value" or "we"), a significant shareholder of Antares Energy Limited (ASX: AZZ) (OTC: AZZEF) ("Antares" or the "Company"), today delivered an open letter to Antares Chairman and CEO, James Cruickshank .
Sign-up for Lone Star Value Delivers Open Letter To Antares Chairman And CEO investment picks
Long-term marketing and supply agreement between Argex Titanium Inc. and HELM U.S. Corp Canada NewsWire MONTREAL and PISCATAWAY, NJ , Aug.
Sign-up for Long-term marketing and supply agreement between Argex Titanium Inc. and HELM U.S. Corp investment picks
New Study Published in The Lancet Respiratory Medicine is First to Provide Strong Evidence Supporting Long-term NPPV in the Treatment of COPD SAN DIEGO , Aug.
Sign-up for Long-term Non-invasive Positive Pressure Ventilation Treatment Delivers 76 Percent Reduction in Risk of Death at One Year among Stable COPD Patients investment picks
GAITHERSBURG, Md., June 18, 2014 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that on June 12, 2014, the Honorable John O.
Sign-up for Long-Time Novavax Board Member Jack Marsh Assumes Role of Director Emeritus investment picks
2014/8/26
LONDON--South African platinum miner Lonmin PLC (LMI.LN) said Tuesday it hasn't made a decision about restructuring after a report said it is planning large-scale job cuts.
Sign-up for Lonmin Says No Decisions Taken On Restructuring investment picks
http://media.marketwire.com/attachments/201111/42905_loralspaceandcomlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1142634&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Loral and SSL Reach Settlement With ViaSat investment picks
WOODCLIFF LAKE, N.J. and SAN DIEGO , Sept.
Sign-up for Lorcaserin HCl Data to be Presented at the American Society of Bariatric Physicians' 64th Annual Obesity & Associated Conditions Symposium investment picks
2014/7/15
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Lorillard, Inc. (NYSE: LO), breached their fiduciary duties in connection with the proposed $27.4 billion sale of the company to R.J. Reynolds Tobacco Company.
Sign-up for LORILLARD ALERT: Proposed Sale of Lorillard, Inc. Being Investigated by Shareholder Rights Law Firm Johnson & Weaver, LLP investment picks
2014/7/15
NEW ORLEANS , July 15, 2014 /PRNewswire/ -- Former Attorney General of Louisiana Charles C.
Sign-up for LORILLARD INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lorillard, Inc. investment picks
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating Lorillard, Inc. NEW YORK, July 15, 2014 /PRNewswire/ -- Juan E.
Sign-up for LORILLARD INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Lorillard, Inc. Board of Directors in Connection With the Proposed Sale of the Company to Reynolds American Inc. investment picks
Andrews & Springer LLC , a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Lorillard, Inc. (“Lorillard” or the “Company”) (NYSE: LO) relating to the sale of the Company to Reynolds American, Inc. (NYSE: RAI) (“Reynolds”). On July 15, 2014, the two companies announced the signing of a definitive merger agreement pursuant to which Reynolds will acquire Lorillard in a merger valued at roughly $27.4 billion.
Sign-up for LORILLARD SHAREHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Lorillard, Inc. - LO investment picks
2014/7/15
NEW YORK , July 15, 2014 /PRNewswire/ -- Tripp Levy PLLC, a leading national securities and shareholder rights law firm, has announced that it is investigating the acquisition of Lorillard Inc. (NYSE: LO) on behalf of investors.
Sign-up for Lorillard Shareholder Alert - Buyout Of Lorillard, Inc (NYSE: LO) - National Securities Law Firm Seeks Higher Price For Shareholders investment picks
2014/7/15
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Lorillard, Inc. (“Lorillard”) (NYSE: LO) concerning the merger with Reynolds American.
Sign-up for LORILLARD SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Merger between Reynolds American and Lorillard May Be Unfair to Shareholders investment picks
NEW YORK (MarketWatch) -- Shares of Lorillard (LO) rallied 4.5% in premarket trade after Reynolds American (RAI) confirmed that it was in discussions regarding a possible acquisition of the cigarette maker.
Sign-up for Lorillard shares rally after Reynolds confirms buyout talks investment picks
2014/9/3
GREENSBORO, N.C. , Sept.
Sign-up for Lorillard Subsidiaries Sue Zippo in the UK to Stop Unfounded Threats Against BLU ECIGS investment picks
2014/7/18
GREENSBORO, N.C. , July 18, 2014 /PRNewswire/ -- Lorillard, Inc. (NYSE: LO) , the third largest tobacco company in the United States , today announced that it will release second quarter 2014 results on Wednesday, July 30, 2014 , before the market opens.
Sign-up for Lorillard to Release Second Quarter 2014 Results on Wednesday, July 30, 2014 investment picks
2014/8/15
GREENSBORO, N.C. , Aug.
Sign-up for Lorillard, Inc. Announces Quarterly Dividend on Common Stock investment picks
2014/7/18
Glancy Binkow & Goldberg LLP is investigating potential claims against the Board of Directors of Lorillard, Inc. (“Lorillard” or the “Company”) (NYSE:LO) related to the proposed merger of the Company with Reynolds American, Inc. The transaction is valued at approximately $27 billion, and under the terms of the agreement, Lorillard shareholders are to receive $50.50 in cash plus 0.2909 shares of Reynolds common stock for each share of Lorillard held, valued at approximately $68.88 per share.
Sign-up for Lorillard, Inc. Board of Directors Under Investigation by Glancy Binkow & Goldberg LLP investment picks
GREENSBORO, N.C. , July 11, 2014 /PRNewswire/ -- Lorillard, Inc. (NYSE: LO) today confirmed that Lorillard and Reynolds American Inc. (NYSE: RAI) ("RAI") are engaged in discussions regarding RAI's potential acquisition of Lorillard.
Sign-up for Lorillard, Inc. Confirms Discussions Regarding Potential Acquisition by Reynolds American Inc. investment picks
GREENSBORO, N.C. , July 30, 2014 /PRNewswire/ -- Lorillard, Inc. (NYSE: LO) announced today its results for the quarter ended June 30, 2014 .
Sign-up for Lorillard, Inc. Reports Second Quarter Results investment picks
2014/7/15
WILMINGTON, Del.
Sign-up for Lorillard, Inc. Shareholder Alert: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
Lorus Therapeutics Implements Name Change to Aptose Biosciences Canada NewsWire TORONTO , Sept.
Sign-up for Lorus Therapeutics Implements Name Change to Aptose Biosciences investment picks
TORONTO , Sept.
Sign-up for Lorus Therapeutics Implements Name Change to Aptose Biosciences investment picks
TORONTO , July 15, 2014 /PRNewswire/ - Lorus Therapeutics Inc. (TSX: LOR) ("Lorus" or the "Company") announces that its shareholders will be asked to approve (i) a change of the corporate name to "Aptose Biosciences Inc." as part of its comprehensive rebranding efforts; and (ii) a consolidation of the common shares of the Company at a ratio within the range of one (1) common share for each five (5) to fifteen (15) common shares (the "Share Consolidation") at its annual and special meeting of shareholders (the "Meeting"). The Meeting will be held at 10:00 a.m. , Toronto time, on August 19, 2014 at the office of McCarthy Tétrault LLP located at Suite 5300, Toronto-Dominion Bank Tower, 66 Wellington Street West, Toronto, Ontario M5K 1E6.
Sign-up for Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Lone Star Value Delivers Open Letter To Antares Chairman And CEO to Lorus Therapeutics Proposes Name Change to "APTOSE BIOSCIENCES" and Share Consolidation for Potential NASDAQ Listing
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices